dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024

DSM-Firmenich Shareholders Approve All Resolutions at Annual General Meeting 2024

Kaiseraugst, Switzerland, and Maastricht, Netherlands, May 7, 2024 - DSM-Firmenich, a leading innovator in nutrition, health, and beauty, announced today that its shareholders have approved all proposals of the Board of Directors at its Annual General Meeting (AGM) held on May 7, 2024.

The AGM was attended by a majority of the company’s shareholders, who voted on various resolutions put forth by the Board of Directors. The approved resolutions include the re-election of three board members, the approval of the company’s financial statements for 2023, and the discharge of the Board of Directors and the Executive Committee from their duties.

The re-election of the three board members, who have served the company for several years, is a testament to their expertise and commitment to the success of DSM-Firmenich. Their continuity will ensure that the company’s strategic direction and decision-making process remain stable and consistent.

The approval of the financial statements for 2023 is a reflection of the company’s strong financial performance last year. Despite challenges posed by the COVID-19 pandemic, DSM-Firmenich was able to deliver robust results, with revenue growth exceeding market expectations. The company’s focus on innovation and sustainability has enabled it to maintain its position as a leader in the nutrition, health, and beauty industry.

The discharge of the Board of Directors and the Executive Committee from their duties is a routine procedure that takes place annually. It is a confirmation by the shareholders that the company’s leadership has performed its duties diligently and in the best interest of the company and its stakeholders.

“We are pleased that our shareholders have approved all resolutions put forth by the Board of Directors,” said Mr. Hans-Joachim Ziesing, Chairman of the Board of Directors at DSM-Firmenich. “Their support is a reflection of the trust they have in our ability to deliver on our strategy and continue to create value for all stakeholders.”

Mr. Ziesing added, “We remain committed to driving innovation, sustainability, and growth at DSM-Firmenich. We will continue to work closely with our customers, partners, and stakeholders to deliver on our purpose of creating brighter lives for all.”

The AGM also provided an opportunity for shareholders to engage with the company’s leadership and discuss various topics, including the company’s strategy, sustainability initiatives, and governance practices. The constructive dialogue and feedback received from shareholders will help shape the company’s future plans and decision-making process.

In conclusion, the approval of all resolutions at DSM-Firmenich’s Annual General Meeting 2024 is a strong endorsement of the company’s strategy, leadership, and commitment to creating value for all stakeholders. The company will continue to build on its strengths and drive growth while maintaining its focus on innovation, sustainability, and customer satisfaction.